<--- Back to Details
First PageDocument Content
Myoclonic astatic epilepsy / Lennox–Gastaut syndrome / Generalised epilepsy / Seizure types / Ketogenic diet / Absence seizure / Anticonvulsant / West syndrome / Epileptic seizure / Epilepsy / Brain / Central nervous system
Date: 2014-03-05 11:46:48
Myoclonic astatic epilepsy
Lennox–Gastaut syndrome
Generalised epilepsy
Seizure types
Ketogenic diet
Absence seizure
Anticonvulsant
West syndrome
Epileptic seizure
Epilepsy
Brain
Central nervous system

Articles The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial Elizabeth G Neal, Hannah Chaffe, Ruby H Schwartz, Margaret S Lawson, Nicole Edwards, Geogianna Fitzsimmons, Andrea Whit

Add to Reading List

Source URL: www.gutbrainaxis.org

Download Document from Source Website

File Size: 121,24 KB

Share Document on Facebook

Similar Documents

A Pilot, Open-Label Study of the Effectiveness and Tolerability of Low-Dose Fenfluramine (ZX008) in Lennox-Gastaut Syndrome: Findings From a Long-Term ExtensionLieven Lagae ; An-Sofie Schoonjans ; Arnold Gammaito

A Pilot, Open-Label Study of the Effectiveness and Tolerability of Low-Dose Fenfluramine (ZX008) in Lennox-Gastaut Syndrome: Findings From a Long-Term ExtensionLieven Lagae ; An-Sofie Schoonjans ; Arnold Gammaito

DocID: 1v1nN - View Document

SpringPractically a Golf Tournament The 22nd Annual Practically a Golf Tournament came to a successful

SpringPractically a Golf Tournament The 22nd Annual Practically a Golf Tournament came to a successful

DocID: 1aOe2 - View Document

Nathan B. Fountain, M.D. Chair, Professional Advisory Board Epilepsy Foundation of America Testimony – Committee on Energy and Commerce Subcommittee on Health Tuesday, January 27, 2015

Nathan B. Fountain, M.D. Chair, Professional Advisory Board Epilepsy Foundation of America Testimony – Committee on Energy and Commerce Subcommittee on Health Tuesday, January 27, 2015

DocID: 199yv - View Document

PUBLIC SUMMARY DOCUMENT Product: Lacosamide, tablets, 50 mg, 100 mg, 150 mg and 200 mg, Vimpat® Sponsor: UCB Australia Pty Ltd Date of PBAC Consideration: NovemberPurpose of Application

PUBLIC SUMMARY DOCUMENT Product: Lacosamide, tablets, 50 mg, 100 mg, 150 mg and 200 mg, Vimpat® Sponsor: UCB Australia Pty Ltd Date of PBAC Consideration: NovemberPurpose of Application

DocID: 18vIe - View Document

Articles  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial Elizabeth G Neal, Hannah Chaffe, Ruby H Schwartz, Margaret S Lawson, Nicole Edwards, Geogianna Fitzsimmons, Andrea Whit

Articles The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial Elizabeth G Neal, Hannah Chaffe, Ruby H Schwartz, Margaret S Lawson, Nicole Edwards, Geogianna Fitzsimmons, Andrea Whit

DocID: 15ZRl - View Document